HEMOGENYX PHARMACEUTICALS PLC
ISIN: GB00BYX3WZ24 | LEI: 2138008L93GYU5GN6179
Country: United Kingdom
5 Fleet Place, EC4M 7RD London – United Kingdom
| Line item in (gbp) | 01.01.2020 | 01.10.2020 | 01.01.2021 | 01.10.2021 | 01.01.2022 | 01.10.2022 | 01.01.2023 |
|---|---|---|---|---|---|---|---|
| Assets | N/A | N/A | 2,664,584.00 | 149,417,000.00 | 466,817,622.00 | 188,181,000.00 | 569,763,215.00 |
| Noncurrent Assets | N/A | N/A | 747,313.00 | 65,811,000.00 | 264,243,946.00 | 79,644,000.00 | 366,218,558.00 |
| Property Plant And Equipment | N/A | N/A | 222,858.00 | 61,039,000.00 | 167,287,970.00 | 74,281,000.00 | 222,663,835.00 |
| Intangible Assets Other Than Goodwill | N/A | N/A | 254,955.00 | 2,424,000.00 | 14,198,244.00 | 3,206,000.00 | 17,464,362.00 |
| Investment Accounted For Using Equity Method | N/A | N/A | N/A | N/A | 0.00 | N/A | 0.00 |
| Investments In Subsidiaries | N/A | N/A | N/A | 0.00 | N/A | 0.00 | N/A |
| Noncurrent Receivables | N/A | N/A | N/A | N/A | 849,489.00 | N/A | 2,407,049.00 |
| Other Noncurrent Receivables | N/A | N/A | N/A | N/A | 2,552,630.00 | N/A | 0.00 |
| Noncurrent Inventories | N/A | N/A | N/A | N/A | 74,895,843.00 | N/A | 118,970,653.00 |
| Deferred Tax Assets | N/A | N/A | N/A | 792,000.00 | N/A | 0.00 | N/A |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss Designated Upon Initial Recognition | N/A | N/A | N/A | N/A | 4,341,709.00 | N/A | 4,621,285.00 |
| Other Noncurrent Assets | N/A | N/A | N/A | N/A | 118,061.00 | N/A | 91,374.00 |
| Current Assets | N/A | N/A | 1,917,271.00 | 83,606,000.00 | 202,573,676.00 | 108,537,000.00 | 203,544,657.00 |
| Inventories | N/A | N/A | N/A | 47,263,000.00 | 100,119,797.00 | 68,351,000.00 | 93,801,461.00 |
| Trade And Other Current Receivables | N/A | N/A | 104,972.00 | 26,371,000.00 | 63,320,703.00 | 37,113,000.00 | 78,162,465.00 |
| Current Prepayments | N/A | N/A | N/A | N/A | 6,346,251.00 | N/A | 6,097,245.00 |
| Current Prepaid Expenses | N/A | N/A | N/A | N/A | 555,554.00 | N/A | 645,285.00 |
| Current Tax Assets Current | N/A | N/A | N/A | 2,701,000.00 | 131,257.00 | 719,000.00 | 924,446.00 |
| Current Loans And Receivables | N/A | N/A | N/A | N/A | 0.00 | N/A | 458,623.00 |
| Cash and cash equivalents | 498,679.00 | 5,250,000.00 | 1,812,299.00 | 247,000.00 | 6,840,969.00 | -3,820,000.00 | 2,532,758.00 |
| Balances With Banks | N/A | N/A | N/A | 7,260,000.00 | N/A | 2,354,000.00 | N/A |
| Current Derivative Financial Assets | N/A | N/A | N/A | 11,000.00 | N/A | 0.00 | N/A |
| Equity And Liabilities | N/A | N/A | 2,664,584.00 | N/A | 466,817,622.00 | N/A | 569,763,215.00 |
| Equity | -349,035.00 | 91,120,000.00 | 222,630,377.00 | 106,299,000.00 | 263,203,182.00 | 133,850,000.00 | 307,154,837.00 |
| Issued Capital | N/A | N/A | 4,336,363.00 | 1,208,000.00 | 1,763,121.00 | 1,217,000.00 | 1,763,121.00 |
| Retained Earnings | N/A | N/A | -8,035,514.00 | 80,083,000.00 | 142,569,353.00 | 96,082,000.00 | 187,644,399.00 |
| Share Premium | N/A | N/A | 9,990,965.00 | 23,484,000.00 | 83,184,367.00 | 23,484,000.00 | 83,184,367.00 |
| Treasury Shares | N/A | N/A | N/A | N/A | 5,532,543.00 | N/A | 1,716,796.00 |
| Other Reserves | N/A | N/A | 764,815.00 | N/A | 5,079,807.00 | N/A | -10,805,505.00 |
| Equity Attributable To Owners Of Parent | N/A | N/A | 890,839.00 | N/A | 242,987,939.00 | N/A | 274,124,708.00 |
| Noncontrolling Interests | N/A | N/A | -15,158.00 | N/A | 20,215,243.00 | N/A | 33,030,129.00 |
| Liabilities | N/A | N/A | 1,788,903.00 | 43,118,000.00 | 203,614,440.00 | 54,331,000.00 | 262,608,378.00 |
| Noncurrent Liabilities | N/A | N/A | 10,028.00 | 12,562,000.00 | 41,481,786.00 | 8,002,000.00 | 80,637,858.00 |
| Noncurrent Government Grants | N/A | N/A | N/A | N/A | 7,215,629.00 | N/A | 12,464,744.00 |
| Deferred Tax Liabilities | N/A | N/A | N/A | 2,175,000.00 | 9,414,581.00 | 5,369,000.00 | 12,198,584.00 |
| Other Noncurrent Financial Liabilities | N/A | N/A | N/A | N/A | 0.00 | N/A | 11,729,130.00 |
| Current Liabilities | N/A | N/A | 1,778,875.00 | 30,556,000.00 | 162,132,654.00 | 46,329,000.00 | 181,970,520.00 |
| Current Provisions | N/A | N/A | N/A | 143,000.00 | N/A | 397,000.00 | N/A |
| Other Shortterm Provisions | N/A | N/A | N/A | N/A | 5,960,310.00 | N/A | 6,320,190.00 |
| Trade And Other Current Payables | N/A | N/A | 160,771.00 | 17,027,000.00 | 75,346,297.00 | 22,903,000.00 | 79,571,978.00 |
| Current Government Grants | N/A | N/A | N/A | N/A | 1,967,532.00 | N/A | 2,011,021.00 |
| Shortterm Employee Benefits Accruals | N/A | N/A | N/A | N/A | 4,671,899.00 | N/A | 5,609,592.00 |
| Current Tax Liabilities Current | N/A | N/A | N/A | 0.00 | 1,053,529.00 | 223,000.00 | 25,524.00 |
| Line item in (gbp) | 01.01.2020/ 01.01.2021 |
01.10.2020/ 01.10.2021 |
01.01.2021/ 01.01.2022 |
01.10.2021/ 01.10.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 124,326,000.00 | 248,133,715.00 | 140,185,000.00 | 302,486,660.00 |
| Other Income | 85,237.00 | N/A | 2,147,737.00 | N/A | 2,754,733.00 |
| Depreciation Expense | 106,753.00 | N/A | 126,340.00 | N/A | 564,072.00 |
| Profit Loss From Operating Activities | -2,150,386.00 | 20,044,000.00 | 62,036,915.00 | 16,696,000.00 | 63,380,105.00 |
| Finance Income | 3,365.00 | 12,000.00 | 7,047,317.00 | 8,000.00 | 442,950.00 |
| Finance Costs | 33,239.00 | 439,000.00 | 6,959,687.00 | 525,000.00 | 10,629,868.00 |
| Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | N/A | N/A | 2,550,417.00 | N/A | -119,227.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | N/A | N/A | -558,114.00 | N/A | 0.00 |
| Profit Loss Before Tax | -2,095,023.00 | 19,617,000.00 | 61,566,431.00 | 16,179,000.00 | 81,452,584.00 |
| Income Tax Expense Continuing Operations | 0.00 | 4,469,000.00 | 10,415,583.00 | 2,864,000.00 | 12,049,685.00 |
| Profit (loss) | -2,095,023.00 | 15,148,000.00 | -5,108,310.00 | 13,315,000.00 | -3,986,982.00 |
| Profit Loss Attributable To Owners Of Parent | -2,082,220.00 | N/A | 47,014,169.00 | N/A | 65,478,130.00 |
| Profit Loss Attributable To Noncontrolling Interests | -12,803.00 | N/A | 4,136,679.00 | N/A | 3,924,769.00 |
| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.10.2020 | 01.10.2021 | 01.01.2022 | 01.10.2022 | 01.01.2023 |
|---|---|---|---|---|---|---|---|
| Profit (loss) | N/A | -2,095,023.00 | N/A | 15,148,000.00 | -5,108,310.00 | 13,315,000.00 | -3,986,982.00 |
| Adjustments For Income Tax Expense | N/A | N/A | N/A | N/A | 10,415,583.00 | N/A | 12,049,685.00 |
| Adjustments For Finance Costs | N/A | N/A | N/A | 270,000.00 | N/A | 382,000.00 | N/A |
| Adjustments For Decrease Increase In Inventories | N/A | N/A | N/A | -11,851,000.00 | -38,633,602.00 | -14,396,000.00 | -29,745,729.00 |
| Adjustments For Increase Decrease In Trade Account Payable | N/A | -35,738.00 | N/A | 4,483,000.00 | -183,736.00 | 4,355,000.00 | -34,184.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | N/A | N/A | N/A | 13,762,336.00 | N/A | 19,130,839.00 |
| Adjustments For Provisions | N/A | N/A | N/A | N/A | -1,266,843.00 | N/A | 0.00 |
| Adjustments For Sharebased Payments | N/A | 363,104.00 | N/A | 1,733,000.00 | 6,391,462.00 | 1,039,000.00 | -340,435.00 |
| Other Adjustments For Noncash Items | N/A | 172.00 | N/A | N/A | 77.00 | N/A | N/A |
| Cash Flows From Used In Operations | N/A | N/A | N/A | 13,442,000.00 | 49,962,793.00 | -1,830,000.00 | 28,260,981.00 |
| Interest Paid Classified As Operating Activities | N/A | N/A | N/A | N/A | 3,881,020.00 | N/A | 3,943,170.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | N/A | N/A | 4,874,000.00 | 11,880,476.00 | -443,000.00 | 9,623,214.00 |
| Cash Flows From Used In Operating Activities | N/A | -1,798,404.00 | N/A | 8,568,000.00 | 34,201,297.00 | -1,387,000.00 | 14,694,597.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | N/A | N/A | 3,226,114.00 | N/A | 4,354,240.00 |
| Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | N/A | N/A | N/A | N/A | 3,414,780.00 | N/A | 0.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | N/A | N/A | 0.00 | 3,004,675.00 | 5,597,000.00 | 857,170.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 173,047.00 | N/A | 13,195,000.00 | 25,125,524.00 | 11,849,000.00 | 32,904,261.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | N/A | N/A | 1,178,000.00 | 696,800.00 | 925,000.00 | 589,635.00 |
| Proceeds From Government Grants Classified As Investing Activities | N/A | N/A | N/A | N/A | 4,684,381.00 | N/A | 692,706.00 |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | N/A | N/A | N/A | 0.00 | 849,488.00 | 0.00 | 1,557,560.00 |
| Interest Received Classified As Investing Activities | N/A | 3,365.00 | N/A | 12,000.00 | 17,958.00 | 8,000.00 | N/A |
| Cash Flows From Used In Investing Activities | N/A | -169,682.00 | N/A | -14,361,000.00 | -21,278,872.00 | -7,169,000.00 | -37,855,820.00 |
| Payments From Changes In Ownership Interests In Subsidiaries | N/A | N/A | N/A | N/A | 5,061.00 | N/A | 0.00 |
| Proceeds From Issuing Shares | N/A | N/A | N/A | 3,000.00 | 1,175,000.00 | 9,000.00 | 0.00 |
| Proceeds From Issuing Other Equity Instruments | N/A | 3,148,200.00 | N/A | N/A | 12,000,000.00 | N/A | N/A |
| Payments To Acquire Or Redeem Entitys Shares | N/A | N/A | N/A | N/A | 4,939,636.00 | N/A | 0.00 |
| Payments Of Other Equity Instruments | N/A | 168,160.00 | N/A | N/A | 0.00 | N/A | N/A |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 461,776.00 | N/A | N/A | 65,756,512.00 | N/A | 118,052,150.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 0.00 | N/A | 674,000.00 | 67,448,002.00 | 360,000.00 | 83,340,957.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 41,249.00 | N/A | 10,000.00 | 39,079.00 | 80,000.00 | N/A |
| Dividends Paid Classified As Financing Activities | N/A | N/A | N/A | 3,704,000.00 | 27,577,478.00 | 4,834,000.00 | 21,803,297.00 |
| Interest Paid Classified As Financing Activities | N/A | N/A | N/A | 282,000.00 | N/A | 390,000.00 | N/A |
| Cash Flows From Used In Financing Activities | N/A | 3,212,022.00 | N/A | 963,000.00 | -33,038,665.00 | 4,378,000.00 | 12,907,896.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 1,243,936.00 | N/A | -4,830,000.00 | 5,211,389.00 | -4,178,000.00 | -3,432,002.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 69,684.00 | N/A | -173,000.00 | 1,427,749.00 | 111,000.00 | 1,608,345.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | N/A | N/A | -5,003,000.00 | N/A | -4,067,000.00 | N/A |
| Cash and cash equivalents | 498,679.00 | 1,812,299.00 | 5,250,000.00 | 247,000.00 | 6,840,969.00 | -3,820,000.00 | 2,532,758.00 |
Please note that some sums might not add up.
GB00BYX3WZ24
LEI2138008L93GYU5GN6179
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.